Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Factor |
Reference |
Bioavailability |
80.0 |
% |
80.0 |
% |
PO, oral; postmenopausal women; Female, women; |
|
The Pharmacological Basis of Therapeutics |
C Max |
46.0 |
ng/ml |
46.0 |
ng/ml |
Oral single dose; postmenopausal women; Female, women; |
|
The Pharmacological Basis of Therapeutics |
T Max |
2.0 |
h |
2 |
h |
PO, oral; fasting; |
|
DRUGBANK |
T Max |
2.0 |
h |
≤2 |
h |
Oral single dose; postmenopausal women; Female, women; |
|
The Pharmacological Basis of Therapeutics |
Volume of Distribution |
3.2 |
L |
3.19 |
mL/g |
mouse; |
|
DRUGBANK |
Half-life |
50.0 |
h |
~50 |
h |
elimination half-life; |
|
DRUGBANK |
Half-life |
50.0 |
h |
50.0 |
h |
normal,healthy; postmenopausal women; Asian; |
|
The Pharmacological Basis of Therapeutics |
Toxicity TDLo |
1.7 |
mg/kg |
1.68 |
mg/kg |
PO, oral; human, homo sapiens; Female, women; |
|
DRUGBANK |
Eliminate Route |
85.0 |
% |
85 |
% |
lung excretion; |
|
DRUGBANK |
Eliminate Route |
10.0 |
% |
~10 |
% |
Urinary excretion; Unchanged drug; |
|
DRUGBANK |
Eliminate Route |
10.0 |
% |
<10 |
% |
Urinary excretion; postmenopausal women; Female, women; normal,healthy; human, homo sapiens; Unchanged drug; |
|
The Pharmacological Basis of Therapeutics |
Protein Binding |
40.0 |
% |
40 |
% |
|
Plasma Concentration → ; |
DRUGBANK |
Protein Binding |
40.0 |
% |
~40 |
% |
postmenopausal women; Female, women; normal,healthy; human, homo sapiens; |
|
The Pharmacological Basis of Therapeutics |